galileo life sciences
biopharma • medical devices • health tech
strategy consulting
growth • innovation • pipeline • portfolio • business plan • cost & assets optimization • shareholder value
financial advisory
capital structure • financing • private placement • equity story
transaction support
licensing • due diligences • mergers & acquisitions • post merger integration • joint ventures • partnerships
Some services are rendered in partnership with Galileo Global Securities, a SEC registered broker-dealer and a member of the Financial Industry Regulatory Authority (FINRA)
Why hire us?
Experience:
Decades of experience, broad industry network
Quality:
We are a small firm but we aim high
Flexibility:
Your needs drive how we work
Integrity:
No compromise
Leadership
Charles-André Brouwers
Paul Sekhri
Mark Kessel
Evonne Sepsis
Carlo de Notaristefani
Corinne Bichon
Managing Partner, Galileo life sciences
Charles-André Brouwers
Charles-André has thirty-year years of experience consulting to the biopharma and medical device industries. He worked closely with the CEOs, Senior Executives, and Boards of many Pharmaceutical and Medtech companies. Previous to founding Galileo Life Sciences, he was Senior Partner and Managing Director at the Boston Consulting Group and before Head of the Life Sciences Group of Capgemini.
Charles-André is a registered representative affiliated with Galileo Global Securities, LLC is a broker-dealer registered with the SEC, a member of the Financial Industry Regulatory Authority (FINRA)
Founding Advisor, Galileo Life Sciences
Paul Sekhri
Paul has decades of experience leading life sciences companies as CEO, Chairman and board member CEO including at vTv Therapeutics, eGenesis, Lycera, Cerimon and ARIAD Pharmaceuticals. He was Chief Strategy Officer at Teva pharmaceutical and Senior Vice President business development and global head, early commercial development at Novartis. Paul is a founding member of Galileo Life Sciences.
Founding Advisor, Galileo Life Sciences
Mark Kessel
Mark has long career in biotech investment. He is known as a pioneer of structured financing. He was a founder and CEO of private equity firm Symphony Capital and a Managing Partner of Shearman & Sterling. Mark is a founding member of Galileo Life Sciences.
Senior Advisor
Evonne Sepsis
Evonne Sepsis has spent over twenty years in healthcare investment banking. Ms. Sepsis founded ESC Advisors, a division of KEMA Partners LLC, a life sciences advisory firm focused on private placements and M&A. KEMA Partners is a FINRA/SIPC member and SEC Registered broker-dealer. Prior to founding ESC Advisors, Ms. Sepsis was head of healthcare investment banking at Susquehanna Financial Group and was a Managing Director at C.E. Unterberg, Towbin. Ms. Sepsis started her investment banking career at Salomon Brothers and before business school, she worked at APM, a healthcare consulting firm.
Executive Advisor
Carlo de Notaristefani
Carlo is an international biopharmaceutical operations senior executive with broad technical, operational, and P&L experience. He has deep expertise in designing, operating, and optimizing complex supply chains. He currently serves on the board of several pharma and CMO companies and advises companies and investors.
In 2020, Carlo joined Operation Warp Speed/Federal Covid Response as the lead advisor for Manufacturing and Supply Chain. His previous roles include Executive VP of Operations at Teva Pharmaceuticals Inc. and President Technical Operations and Global Support Functions for Bristol Myers Squibb.
Chief of Staff
Corinne Bichon
Corinne oversees all office services and human resources activities. She is also the primary point of contact for internal and external stakeholders